Yahoo Web Search

Search results

  1. For ADHD core symptoms rated by clinicians in children and adolescents closest to 12 weeks, all included drugs were superior to placebo (eg, SMD –1·02, 95% CI –1·19 to –0·85 for amphetamines, –0·78, –0·93 to –0·62 for methylphenidate, –0·56, 0·66 to –0·45 for atomoxetine).

  2. Feb 1, 2022 · The recommended starting dose is 0.1 mg tablet at bedtime, which can then be increased to a twice-daily administration and subsequent careful uptitration. Doses higher than 0.4 mg/day are not recommended.

    • Konstantin Mechler, Tobias Banaschewski, Sarah Hohmann, Alexander Häge
    • 2021
  3. Based on a search in PubMed and PsycInfo (up to 15 September 2022), this review addresses to which extent this body of research is currently able to inform routine prescribing practice, in terms of the choice of medication, titration strategy, augmentation treatments, and use of alternative, non-approved treatments.

  4. Jan 28, 2021 · At the end of a 6-week, open-label, dose-optimization period in one study, the mean daily optimized dose was 66.2 mg (SD=19.56) . Although the FDA-recommended starting dose is 20 mg, most patients will not achieve optimal symptom control until higher doses are prescribed.

  5. Jan 14, 2022 · Clinical guidelines currently recommend practitioners titrate stimulant medications, i.e., methylphenidate (MPH) and amphetamines (AMP), to the dose that maximizes symptom control without ...

  6. May 29, 2024 · Detailed dosage guidelines and administration information for Adderall (dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate). Includes dose adjustments, warnings and precautions.

  7. Clinical guidelines currently recommend practitioners titrate stimulant medications, i.e., methylphenidate (MPH) and amphetamines (AMP), to the dose that maximizes symptom control without...

  1. People also search for